Evidence map›Paper›PMID 32880739›Full record

ReviewCurrent hypertension reports2020

Hypertension and Age-Related Cognitive Impairment: Common Risk Factors and a Role for Precision Aging.

Meredith Hay, Carol Barnes, Matt Huentelman, Roberta Brinton, Lee Ryan

Open access · hybridAbstract readReview
In one paragraph

Review in Current hypertension reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside (TSG) fromInternational journal of molecular sciences · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Peripheral CD4Immunity & ageing : I & A · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Vascular calcium signalling and ageing.The Journal of physiology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Meredith HayDepartment of Physiology, University of Arizona, 1501 N Campbell Rd, Room 4103, Tucson, AZ, 85724, USA. mhay@arizona.edu.ORCID http://orcid.org/0000-0003-4027-1545
Carol BarnesPsychology Department, University of Arizona, Tucson, AZ, USA.
Matt HuentelmanEvelyn F. McKnight Brain Institute, University of Arizona, Tucson, AZ, USA.
Roberta BrintonEvelyn F. McKnight Brain Institute, University of Arizona, Tucson, AZ, USA.
Lee RyanPsychology Department, University of Arizona, Tucson, AZ, USA.
University of Arizona · USTranslational Genomics Research Institute · US

Funding

IND Enabling Studies for a Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Alzheimer's Disease Related DementiaU01AG066623 · NIA · UNIVERSITY OF ARIZONA · PI HAY, MEREDITH, KONHILAS, JOHN P · 2020 to 2023
$8.0M
NIA NIH HHS U01 AG066623NIA NIH HHS U01 AG066623-01
6 · The paper itself

Abstract

purpose of reviewPrecision Aging® is a novel concept that we have recently employed to describe how the model of precision medicine can be used to understand and define the multivariate risks that drive age-related cognitive impairment (ARCI). Hypertension and cardiovascular disease are key risk factors for both brain function and cognitive aging. In this review, we will discuss the common mechanisms underlying the risk factors for both hypertension and ARCI and how the convergence of these mechanisms may be amplified in an individual to drive changes in brain health and accelerate cognitive decline. RECENT

findingsCurrently, our cognitive health span does not match our life span. Age-related cognitive impairment and preventing and treating ARCI will require an in-depth understanding of the interrelated risk factors, including individual genetic profiles, that affect brain health and brain aging. Hypertension and cardiovascular disease are important risk factors for ARCI. And, many of the risk factors for developing hypertension, such as diabetes, smoking, stress, viral infection, and age, are shared with the development of ARCI. We must first understand the mechanisms common to the converging risk factors in hypertension and ARCI and then design person-specific therapies to optimize individual brain health. The understanding of the convergence of shared risk factors between hypertension and ARCI is required to develop individualized interventions to optimize brain health across the life span. We will conclude with a discussion of possible steps that may be taken to decrease ARCI and optimize an individual's cognitive life span.

Indexed as

AgingCognitive DysfunctionBrainHumansHypertensionPrecision MedicineRisk FactorsCognitive agingCOVID-19HypertensionPrecision agingRisk factors

Identifiers

PMID32880739
PMCPMC7467861
OpenAlexW3081962257

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.